|
Live Webcast of Endopelvic Fascia Sparing Robotic Prostatectomy Performed by David B. Samadi, M.D.
(Marketwire Via Acquire Media NewsEdge) NEW YORK, NY, October 14 / MARKET WIRE/ --
"There's simply no question that robotic prostate surgery is the future
and I was so happy to answer questions and share my expertise with cancer
patients and doctors who are curious about the procedure," said Dr. David
Samadi on hosting his live webcast about endopelvic fascia sparing robotic
surgery on OR-Live.com, August 13, 2008. The webcast was moderated by Simon
Hall, MD, who is Chair of the Department of Urology and Director of the
Barbara and Maurice A. Deane Prostate Health and Research Center at Mount
Sinai. David Samadi, MD, is Chief of Robotics and Minimally Invasive
Surgery at Mount Sinai. At the start of the webcast, Dr. Simon Hall
remarked, "This is a very exciting time in urology because of what robotic
technology has made possible -- it's enabled unprecedented advancements."
Dr. Samadi uses the da Vinci S HD Surgical System designed by Intuitive
Surgical. He's insistent that robotic technology makes a marked difference
in patients' quality of life after a prostatectomy because the patient
retains potency and continence, which is not always the case with open or
traditional surgery. Removing the cancer is not the only goal anymore,
which makes a significant difference in people's lives. "Patients want to
be cancer-free, they want to have sexual function and they want to be
continent," says Samadi.
Although the robotic technology is state-of-the-art, the experience of the
surgeon is an important factor in positive outcomes. The technology acts as
an expert assistant with the doctor present throughout, conducting every
step of the surgery. Dr. Samadi has performed over 1,500 robotic
prostatectomies and, on average, performs 10 to 15 robotic surgeries
per week. He is also trained in open and laparoscopic surgery and brings
these techniques to bear, when useful, during robotic operations. As he
says, "I'm 3 surgeons in one head."
Dr. Samadi's robotic prostate removal requires only five small "keyhole"
incisions in the patient's abdomen, through which delicate instruments are
inserted along with a camera that shows magnified images from inside the
body onto a screen. The da Vinci surgery system creates 3D
representations and filters and scales the surgeon's hand movements, making
them more precise than has ever been possible.
The smaller incisions mean far less blood loss in comparison to open
surgery, where the incision must be between 7 and 10 inches long, in order
to remove a small, walnut-sized organ. As a point of comparison, blood loss
during open surgery is typically 500-700 cc, during laparoscopic it's
300-400 cc and for robotic surgeries, 50-100 cc, which is the equivalent of
a few tablespoons.
Robotic surgery reduces the duration of the prostatectomy to 1 to 2 hours. In the open procedure,
the surgery takes 2.5-3.5 hours, and for a laparoscopic operation, it's
3.5-4.5 hours. Most patients are discharged from the hospital within 24
hours of robotic surgery instead of the 2 to 4 days required of patients
undergoing open and laparoscopic procedures.
Samadi summed up the benefits of robotic prostate
surgery with his "Rule of Ones," that demonstrates the benefits of robotic surgery
technology:
-- Surgery is approximately ONE hour
-- Hospital stay is only ONE day
-- Catheter for just ONE week
-- Recovery is ONE month
Because robotic surgery is more precise than the pre-existing prostate
cancer treatment techniques, positive margin rates are lower for
patients who have had robotic operations. Surgical margin rates measure the
risk of cancer recurrence, making a low positive margin percentage what a
surgeon seeks. The overall positive margin rate at Mount Sinai is 6.6%.
At the end of the OR-Live webcast, after live questions were fielded and
answered by both Doctors Samadi and Hall and case video had been discussed,
Dr. Samadi said this in conclusion: "There is no greater joy as a surgeon
than to look at your patient and say you're cured, your PSA
(prostate-specific antigen) is undetectable and you can move on."
About David B. Samadi
David B. Samadi, MD, is a board-certified urologic surgeon trained in open,
laparoscopic, and robotic surgery. He is one of the world's most
experienced da Vinci surgeons with a professionally acknowledged level of
success. Dr. Samadi is one of the only surgeons in the country to have
completed two fellowships: one in oncology at Memorial Sloan Kettering
Cancer Center in New York, and the other in laparoscopy at Henri Mondor
Hospital in France.
Dr. Samadi has completed more than 1,500 da Vinci cases in his career, and
since his arrival at Mt. Sinai a year ago, he has performed nearly 600
robotic operations. Dr. Samadi has proctored and taught urologists across
the world how to perform the endopelvic fascia sparing robotic prostatectomy procedure. Dr. Samadi's robotic
surgery program at Mount Sinai is unique in its ability to combine the
advanced technology of robotics with the expertise of open and laparoscopic
skills.
To contact Dr. Samadi, please call 1-888-Robot10 (1-888-762-6810), or visit
his website: www.roboticoncology.com.
About Simon J. Hall
Simon J. Hall, MD, is chairman of Mount Sinai's Department of Urology and
Director of the Barbara and Maurice Deane Prostate Health and Research
Center at Mount Sinai School of Medicine. For information about Dr. Hall's
expertise please contact him at 212-241-3743.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=853420
Video-Link Available: http://www2.marketwire.com/mw/frame_mw?attachid=853469
Add to Digg Bookmark with del.icio.us Add to Newsvine
David B. Samadi, MD
1-888-Robot10 (1-888-762-6810)www.roboticoncology.com
Simon J. Hall, MD
212-241-3743
Copyright ? 2008 Marketwire
[ Back To TMCnet.com's Homepage ]
|
INDUSTRIES
Activate Email 
INDUSTRIES
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO West, September 1-3, 2009. Los Angeles, CA.
